chr22-38991444-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004900.5(APOBEC3B):āc.836T>Gā(p.Ile279Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000208 in 1,441,620 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000034 ( 0 hom., cov: 30)
Exomes š: 0.0000021 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
APOBEC3B
NM_004900.5 missense
NM_004900.5 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 1.77
Genes affected
APOBEC3B (HGNC:17352): (apolipoprotein B mRNA editing enzyme catalytic subunit 3B) This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. A hybrid gene results from the deletion of approximately 29.5 kb of sequence between this gene, APOBEC3B, and the adjacent gene APOBEC3A. The breakpoints of the deletion are within the two genes, so the deletion allele is predicted to have the promoter and coding region of APOBEC3A, but the 3' UTR of APOBEC3B. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOBEC3B | ENST00000333467.4 | c.836T>G | p.Ile279Ser | missense_variant | 6/8 | 1 | NM_004900.5 | ENSP00000327459.3 | ||
APOBEC3B | ENST00000407298.7 | c.761T>G | p.Ile254Ser | missense_variant | 6/8 | 1 | ENSP00000385068.3 | |||
APOBEC3B | ENST00000335760.9 | n.682T>G | non_coding_transcript_exon_variant | 5/7 | 1 | ENSP00000338897.5 | ||||
APOBEC3B | ENST00000402182.7 | c.836T>G | p.Ile279Ser | missense_variant | 6/7 | 2 | ENSP00000385060.3 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 5AN: 147744Hom.: 0 Cov.: 30 FAILED QC
GnomAD3 genomes
AF:
AC:
5
AN:
147744
Hom.:
Cov.:
30
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000208 AC: 3AN: 1441620Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 717418
GnomAD4 exome
AF:
AC:
3
AN:
1441620
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
717418
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000338 AC: 5AN: 147744Hom.: 0 Cov.: 30 AF XY: 0.0000557 AC XY: 4AN XY: 71790
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
5
AN:
147744
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
71790
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2024 | The c.836T>G (p.I279S) alteration is located in exon 6 (coding exon 6) of the APOBEC3B gene. This alteration results from a T to G substitution at nucleotide position 836, causing the isoleucine (I) at amino acid position 279 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
0.67
.;.;P
Vest4
MutPred
0.74
.;Gain of catalytic residue at I279 (P = 0.0057);Gain of catalytic residue at I279 (P = 0.0057);
MVP
MPC
3.6
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at